{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:10:47Z","timestamp":1791882647534,"version":"4.3.4"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"crossref","award":["205785"],"award-info":[{"award-number":["205785"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT104422MA"],"award-info":[{"award-number":["WT104422MA"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002895","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T17:21:56Z","timestamp":1569000116000},"page":"e1002895","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":106,"title":["Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A\u00a0randomised trial (DolPHIN-1 study)"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-5855","authenticated-orcid":true,"given":"Catriona","family":"Waitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Walimbwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Kintu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryony","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9510-0474","authenticated-orcid":true,"given":"Julian","family":"Kaboggoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sihlangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-6257","authenticated-orcid":true,"given":"Julie-Anne","family":"Coombs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoko","family":"Malaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3438-9662","authenticated-orcid":true,"given":"Josaphat","family":"Byamugisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alieu","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Gini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Else","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Heiburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-1685","authenticated-orcid":true,"given":"Eva Maria","family":"Hodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-4520","authenticated-orcid":true,"given":"Helen","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-3171","authenticated-orcid":true,"given":"Ushma","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-1968","authenticated-orcid":true,"given":"Pauline","family":"Byakika-Kibwika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8106-7658","authenticated-orcid":true,"given":"Landon","family":"Myer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Lamorde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-0967","authenticated-orcid":true,"given":"Saye","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"pmed.1002895.ref001","doi-asserted-by":"crossref","first-page":"20045","DOI":"10.7448\/IAS.18.1.20045","article-title":"Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa","volume":"18","author":"L Myer","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"pmed.1002895.ref002","doi-asserted-by":"crossref","first-page":"e0138104","DOI":"10.1371\/journal.pone.0138104","article-title":"Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, China","volume":"10","author":"K Meyers","year":"2015","journal-title":"PLoS One"},{"issue":"19","key":"pmed.1002895.ref003","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa1215541","article-title":"Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection","volume":"369","author":"SL Walmsley","year":"2013","journal-title":"N Engl J Med"},{"issue":"14","key":"pmed.1002895.ref004","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/QAD.0b013e32834a1dd9","article-title":"Antiviral activity, safety, and pharmacokinetics\/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults","volume":"25","author":"S Min","year":"2011","journal-title":"AIDS"},{"issue":"1","key":"pmed.1002895.ref005","first-page":"4","article-title":"Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy","volume":"16","author":"G Meintjes","year":"2015","journal-title":"S Afr Med J"},{"key":"pmed.1002895.ref006","unstructured":"The Integrated National Guidelines on Antiretroviral Therapy, Prevention of Mother to Child Transmission of HIV and Infant and Young Child Feeding. The Republic of Uganda. 2012. http:\/\/library.health.go.ug\/publications\/hivaids\/integrated-national-guidelines-antiretroviral-therapy-prevention-mother-child, Accessed 17 July 2019"},{"key":"pmed.1002895.ref007","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jchromb.2016.05.040","article-title":"The development and application of a novel LC-MS\/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma","volume":"1027","author":"SD Penchala","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"pmed.1002895.ref008","article-title":"Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milk","author":"J Gini","year":"2018","journal-title":"Bioanalysis"},{"issue":"12","key":"pmed.1002895.ref009","doi-asserted-by":"crossref","first-page":"e28096","DOI":"10.1371\/journal.pone.0028096","article-title":"Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool","volume":"6","author":"RM Gallagher","year":"2011","journal-title":"PLoS One"},{"key":"pmed.1002895.ref010","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1192\/bjp.150.6.782","article-title":"Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale","volume":"150","author":"JL Cox","year":"1987","journal-title":"Br J Psychiatry"},{"issue":"1","key":"pmed.1002895.ref011","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1128\/AAC.00842-09","article-title":"Pharmacokinetics and safety of S\/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers","volume":"54","author":"S Min","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"pmed.1002895.ref012","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40262-013-0093-2","article-title":"Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir","volume":"52","author":"ML Cottrell","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"pmed.1002895.ref013","unstructured":"Electronic Medicines Compendium. Tivicay film-coated tablets. Summary of product characteristics. 2018. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/5248\/smpc."},{"issue":"6","key":"pmed.1002895.ref014","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/QAD.0000000000001755","article-title":"Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV","volume":"32","author":"N Mulligan","year":"2018","journal-title":"AIDS"},{"key":"pmed.1002895.ref015","unstructured":"Bollen P, Colbers A, Schalkwijk S, Velthoven-Graafland K, Konopnicki D, Weizsacker K, et al., editors. First report of dolutegravir unbound plasma concentrations during pregnancy in HIV-positive women. 19th International Workshop on Clinical Pharmacology of Antiviral Therapy; 2018; Baltimore, USA."},{"issue":"10","key":"pmed.1002895.ref016","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40262-012-0002-0","article-title":"Pharmacokinetic optimization of antiretroviral therapy in pregnancy","volume":"51","author":"K Buckoreelall","year":"2012","journal-title":"Clin Pharmacokinet"},{"issue":"17","key":"pmed.1002895.ref017","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1097\/QAD.0000000000001259","article-title":"Dolutegravir in breast milk and maternal and infant plasma during breastfeeding","volume":"30","author":"R Kobbe","year":"2016","journal-title":"AIDS"},{"issue":"6","key":"pmed.1002895.ref018","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1128\/AAC.00173-15","article-title":"Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy","volume":"59","author":"JB Pain","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"pmed.1002895.ref019","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception","volume":"379","author":"R Zash","year":"2018","journal-title":"N Engl J Med"},{"key":"pmed.1002895.ref020","volume-title":"Statement on DTG","author":"WHO","year":"2018"},{"issue":"7","key":"pmed.1002895.ref021","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1016\/S2214-109X(18)30218-3","article-title":"Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study","volume":"6","author":"R Zash","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"2","key":"pmed.1002895.ref022","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S2055-6640(20)30247-8","article-title":"Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review","volume":"4","author":"A Hill","year":"2018","journal-title":"J Virus Erad"},{"issue":"6","key":"pmed.1002895.ref023","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199908053410602","article-title":"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group","volume":"341","author":"PM Garcia","year":"1999","journal-title":"N Engl J Med"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T19:54:53Z","timestamp":1611258893000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002895"}},"subtitle":[],"editor":[{"given":"Lynne Meryl","family":"Mofenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002895","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]}}}